Glaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia

Glaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia

(See:The Hidden Agenda Behind The FDA's Avandia Hearings.) This is the GlaxoSmithKline GlaxoSmithKline's prepared statement in response to that article. The FDA's response can be found here. Many inaccuracies exist in Dr. Nissen's commentary and

2
Like
Save

Comments

Write a comment

*